ARVINAS, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
ARVINAS, INC. (ARVN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00.
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $1.50M, a 82.35% decline from fiscal 2024.
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $8.50M.
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ARVINAS, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $2.40M, a 25.00% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 1 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $1.50M 10-K · filed 2026-02-24 | |||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $1.50M 10-Q · filed 2025-11-05 | $10.00M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.50M 10-Q · filed 2026-08-04 | $10.00M derived: sum of 3 quarters · filed 2026-08-04 | $10.00M derived: sum of 4 quarters · filed 2026-08-04 | |||||
| 2025-03-31 | $1.50M 10-Q · filed 2026-05-11 | $10.00M derived: sum of 2 quarters · filed 2026-05-11 | $10.00M derived: sum of 3 quarters · filed 2026-05-11 | $10.00M derived: sum of 4 quarters · filed 2026-05-11 | |||||
| 2024-12-31 | $1.50M 10-K · filed 2026-02-24 | $8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.50M derived: sum of 2 quarters · filed 2026-02-24 | $8.50M derived: sum of 3 quarters · filed 2026-02-24 | $8.50M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | |||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | |||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | |||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-07-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-02-11 | |||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 derived: sum of 3 quarters · filed 2025-02-11 | $0.00 derived: sum of 4 quarters · filed 2025-02-11 | |||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2025-02-11 | $0.00 derived: sum of 3 quarters · filed 2025-02-11 | $0.00 derived: sum of 4 quarters · filed 2025-02-11 | |||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $0.00 derived: sum of 2 quarters · filed 2025-02-11 | $0.00 derived: sum of 3 quarters · filed 2025-02-11 | $2.40M 10-K · filed 2025-02-11 | |||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $2.40M 10-Q · filed 2023-11-07 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | |||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.40M 10-Q · filed 2023-08-08 | $2.40M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | |||||
| 2022-03-31 | $2.40M 10-Q · filed 2023-05-05 | $2.40M derived: sum of 2 quarters · filed 2024-02-27 | $2.40M derived: sum of 3 quarters · filed 2024-02-27 | $2.40M derived: sum of 4 quarters · filed 2024-02-27 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $3.20M 10-K · filed 2024-02-27 | |||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $3.20M 10-Q · filed 2022-11-09 | $3.19M 10-Q · filed 2021-11-03 | $3.23M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.20M 10-Q · filed 2022-08-04 | $3.19M 10-Q · filed 2021-08-05 | $3.23M derived: sum of 3 quarters · filed 2023-02-23 | $3.25M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $3.20M 10-Q · filed 2022-05-05 | $3.19M 10-Q · filed 2021-05-04 | $3.23M derived: sum of 2 quarters · filed 2023-02-23 | $3.25M derived: sum of 3 quarters · filed 2023-02-23 | $3.26M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $27.59K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $53.39K derived: sum of 2 quarters · filed 2023-02-23 | $58.63K derived: sum of 3 quarters · filed 2023-02-23 | $600.00K 10-K · filed 2023-02-23 | $572.41K 10-K · filed 2021-03-01 | ||||
| 2020-09-30 | $25.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $31.04K derived: sum of 2 quarters · filed 2021-11-03 | $572.41K 10-Q · filed 2021-11-03 | $776.43K derived: sum of 4 quarters · filed 2021-11-03 | |||||
| 2020-06-30 | $5.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $546.61K 10-Q · filed 2021-08-05 | $750.63K derived: sum of 3 quarters · filed 2021-08-05 | $752.18K derived: sum of 4 quarters · filed 2021-08-05 | |||||
| 2020-03-31 | $541.37K 10-Q · filed 2021-05-04 | $745.39K derived: sum of 2 quarters · filed 2021-05-04 | $746.94K derived: sum of 3 quarters · filed 2021-05-04 | ||||||
| 2019-12-31 | $204.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $205.57K derived: sum of 2 quarters · filed 2021-03-01 | $571.89K 10-K · filed 2021-03-01 | $571.88K 10-K · filed 2020-03-16 | |||||
| 2019-09-30 | $1.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $367.87K 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | $366.32K 10-Q · filed 2020-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |